Trial Profile
Gemcitabine plus cisplatin as neoadjuvant chemotherapy in operable non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2005
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Nov 2005 New trial record.